Growth momentum Repligen posted a 2025 revenue of $738.3 million, up 16% year over year, indicating expanding bioprocessing demand and potential for upsell of advanced filtration, chromatography, and process analytics solutions.

European expansion The opening of the Training & Innovation Center in Breda, Netherlands, signals a strengthened regional support and localized service capability that can be leveraged to cross-sell training packages, advanced resins, and expanded manufacturing workflow solutions in Europe.

Product portfolio Launch of AVIPure HiPer AAV9/AAV8 resins and HiPer QA resin expands protein processing capabilities; opportunities exist to position these resins with gene therapy, AAV vector manufacturing, and high-performance chromatography needs across biopharma customers.

Strategic partnerships Continued focus on bioprocessing leadership, with a global footprint across 22 sites, offers cross-sell opportunities for filtration, chromatography systems, process analytics, and fluid management across CDMOs, biotech startups, and mAb/ADC/bispecific programs.

Leadership & capacity New leadership appointment for accounting signals governance maturity; combined with substantial funding and a scalable operations network, presenting a favorable environment for multi-year supply agreements, training contracts, and long-cycle equipment and resin sourcing deals.